Sandra L Venzie LPC

Recommended Articles

• Study Suggests that Self-Reported Celiac Disease Could Be Due to Another Molecule

  Although medical statics show that celiac disease and gluten allergies are present in only a small number of people (less than 1%), a large number of people are claiming to suffer from celiac disease and reporting benefits from a gluten-free diet, even without a proper diagnosis. Perhaps, what is...

• What are the Early Signs of Lupus?

  Systemic lupus erythematosus (also known as lupus) is a condition that usually affects women. It occurs as a result of antibodies or lymphocytes generated against substances that exist in the body. Approximately one out of 2,100 people has the condition.Women are five times more vulnerable to...

• Medical Treatments for Croup

  Croup, a common viral condition, causes swelling in a child’s airway, making it hard to breathe. This is because the already-narrow airway is made even narrower. This viral infection often starts as a common cold, which is then followed by a harsh, barking sound, especially at night. It is also...

• Laryngitis: How Can a Nonsteroidal Anti-Inflammatory Drug Help Me?

  Laryngitis is a condition in which the larynx (voice box) and the vocal cords become inflamed.Conventional Laryngitis TreatmentsLaryngitis can sometimes be treated at home by drinking lots of fluids, resting your voice, breathing humidified air, and sucking on lozenges. Refraining from consumption...

• What is Rheumatic Fever?

  Rheumatic fever is a complicated, nonsuppurative disease that affects the joints, blood vessels, heart, brain, and skin. It is an acute inflammatory response that has a PAST untreated or slightly treated Group A or group B beta-hemolytic streptococcal infection, such as strep throat or scarlet...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...